A pulsatile control algorithm of continuous-flow pump for heart recovery

The intra-aorta pump is a novel continuous flow (CF) left ventricular (LV) device. According to literatures, the pulsatile flow LV device can provide superior LV unloading and circulatory support compared with CF LV assist devices at the same level of ventricular assist device flow. Therefore, a pulsatile control algorithm for the intra-aorta pump is designed. It can regulate the pump to generate pulsatile arterial pressure (AP) and blood flow. A mathematic model of the cardiovascular-pump system is used to verify the feasibility of the control strategy in the presence of LV failure. The surplus hemodynamic energy (SHE), pulsatile ratio (PR), and pulsatile attenuation index (PAI) are used to evaluate the pulsatility of AP and blood flow. The SHE is 8,012.0 ergs/cm(3) by using the pulsatile control strategy (PCS) compared with 5,630.0 ergs/cm(3) by failing heart without support. The PR is 0.302 in the PCS vs. 0.315 in failing heart without support. Meanwhile, the PAI is 85.9% in the PCS compared with 69.7% in failing heart without support. The results demonstrate that the presented control strategy can maintain the pulsatility of AP and blood flow. Moreover, the pulsatile controller provides notably LV unloading. To test the response of the controller to the change of blood demand of patients, another simulation is conducted. In this simulation, the peripheral resistance is reduced to mimic the status of a slight physical active; the Emax is increased to simulate the ventricular contractility recovery. The simulation results demonstrate that the proposed control strategy can automatically regulate the pump in response to the change of the parameters of the circulatory system. To test the dynamic character of the intra-aorta pump, an in vitro experiment is conducted on an in vitro experiment rig. The experimental results demonstrate that the intra-aorta pump can achieve the pulsatile pump speed calculated by the pulsatile controller. The PCS is feasible for the intra-aorta pump. As a key feature, the proposed control strategy provides adequate perfusion in response to the change of blood demands of patients, while restoring the pulsatility of AP and blood flow.     

Modeling and identification of an intra-aorta pump

The intra-aorta pump is a novel left ventricular assist device (LVAD) that assists the heart without the need for percutaneous wires and conduits. It is implanted between the radix aortae and the aortic arch to avoid damage to the aortic valve. To predict the mean pressure head and blood flow, a nonlinear lumped parameter model, which does not need the parameters of the circulatory system, is established. The model includes a speed-controlled current source, an internal resistor, and an inductance for simulating the pressure-flow rate relationship. The speed-controlled current source is used to represent the blood flow caused by the kinetic energy from the impeller, the internal resistor is used to stimulate the resistance character of the radial clearance of the intra-aorta pump, and the inductance is used to model the inertia of the blood that passes through the radial clearance. Each part of the model has clear physical significance, which is helpful for extending the model to other blood pumps. It can generate all status of the pump from suction to pulmonary congestion. The model is summarized as a function of the pressure head, the blood flow, and rotational speed of which the values of parameters in the model are determined by experiment. The model and prediction method are tested experimentally on an in vitro mock loop. A comparison of the predicted pressure head obtained from our model with experimental data shows that our model can predict the differential pressure accurately with error <5% for all experimental conditions over the entire range of intended use of the intra-aorta pump.     

Effect of LVAD outlet graft anastomosis angle on the aortic valve, wall, and flow

Left ventricular assist devices (LVADs), which pump blood from the left ventricle to the aorta are an important therapy option for patients with end-stage cardiovascular diseases. Recent publications show that even with optimized LVADs fatal complications can occur because of the blood deformations around the inflow cannula or through the LVAD outlet graft-aorta anastomosis. This study investigates the effects of the anastomosis geometry on the flow through the aorta, on the pressure and wall shear stress (WSS) distributions on the aortic wall and on the total entropy generation in the anastomosis region. Anastomosis geometry is defined with two angles, one on the coronal plane and the other on the transversal plane. Turbulent flow simulations are performed for each geometry. Results indicate that 3% to 5% of the work given by the LVAD is dissipated because of the viscous losses in the anastomosis region. The entropy generation, as well as the maximum WSS, increases as the inclination angle decreases. Some portion of the blood streaming out of the LVAD conduit flows toward the aortic valve; therefore the reverse-flow region extends up to the aortic valve in some cases, which may be one of the causes of aortic-valve dysfunction. Results of this study provide insight on the importance of the anastomosis geometry on the hemodynamics in the aorta and downstream the aortic valve, stresses on the aortic wall, and viscous losses.     

Precise quantification of pressure flow waveforms of a pulsatile ventricular assist device

Unreliable quantification of flow pulsatility has hampered many efforts to assess the importance of pulsatile perfusion. Generation of pulsatile flow depends upon an energy gradient. It is necessary to quantify pressure flow waveforms in terms of hemodynamic energy levels to make a valid comparison between perfusion modes during chronic support. The objective of this study was to quantify pressure flow waveforms in terms of energy equivalent pressure (EEP) and surplus hemodynamic energy (SHE) levels in an adult mock loop using a pulsatile ventricle assist system (VAD). A 70 cc Pierce-Donachy pneumatic pulsatile VAD was used with a Penn State adult mock loop. The pump flow rate was kept constant at 5 L/min with pump rates of 70 and 80 bpm and mean aortic pressures (MAP) of 80, 90, and 100 mm Hg, respectively. Pump flows were adjusted by varying the systolic pressure, systolic duration, and the diastolic vacuum of the pneumatic drive unit. The aortic pressure was adjusted by varying the systemic resistance of the mock loop EEP (mm Hg) = (integral of fpdf)/(integral of fdt) SHE (ergs/cm3) = 1,332 [((integral of fpdt)/(integral of fdt))--MAP] were calculated at each experimental stage. The difference between the EEP and the MAP is the extra energy generated by this device. This difference is approximately 10% in a normal human heart. The EEP levels were 88.3 +/- 0.9 mm Hg, 98.1 +/- 1.3 mm Hg, and 107.4 +/- 1.0 mm Hg with a pump rate of 70 bpm and an aortic pressure of 80 mm Hg, 90 mm Hg, and 100 mm Hg, respectively. Surplus hemodynamic energy in terms of ergs/cm3 was 11,039 +/- 1,236 ergs/cm3, 10,839 +/- 1,659 ergs/cm3, and 9,857 +/- 1,289 ergs/cm3, respectively. The percentage change from the mean aortic pressure to EEP was 10.4 +/- 1.2%, 9.0 +/- 1.4%, and 7.4 +/- 1.0% at the same experimental stages. Similar results were obtained when the pump rate was changed from 70 bpm to 80 bpm. The EEP and SHE formulas are adequate to quantify different levels of pulsatility for direct and meaningful comparisons. This particular pulsatile VAD system produces near physiologic hemodynamic energy levels at each experimental stage.     

主动脉内经皮左心室辅助泵出口处流场非定常模拟分析及其影响

目的:分析主动脉内经皮左心室辅助泵出口处的径向血流及其对主动脉内皮细胞造成损伤的可能性。方法:运用计算流体力学（CFD）对一款经皮左心室辅助泵在主动脉直径分别为20、30、40 mm 3种情况下进行非定常数值仿真,分析血泵出口处的流场分布。通过研究其速度、压力和剪切应力分布情况来分析血泵径向血流对主动脉血管内皮细胞的影响。结果:数据结果显示,血泵出口处的径向血流对3个模型额外增加的正应力分别为24、17、8 mmHg,近壁面剪切应力大于25 Pa的比例分别为19.3%、13.6%、3.0%。结论:实验表明,经皮左心室辅助泵的植入会增大主动脉压和近壁面剪切应力,而且主动脉直径越小,其效果越明显,因此对于主动脉直径偏小、患有高血压或动脉病变的患者应谨慎使用。     

The effect of left ventricular function and drive pressures on the filling and ejection of a pulsatile pediatric ventricular assist device in an acute animal model

Penn State is currently developing a 12-mL, pulsatile, pneumatically driven pediatric ventricular assist device intended to be used in infants. After extensive in vitro testing of the pump in a passive-filling, mock circulatory loop, an acute animal study was performed to obtain data with a contracting ventricle. The objectives were to determine the range of pneumatic pressures and time required to completely fill and empty the pediatric ventricular assist device under various physiologic conditions, simulate reductions in ventricular contractility and blood volume, and provide data for validation of the mock circulatory loop. A 15-kg goat was used. The cannulation was achieved via left thoracotomy from the left ventricle to the descending aorta. The pump rate and systolic duration were controlled manually to maintain complete filling and ejection. The mean ejection time ranged from 280 ms to 382 ms when the systolic pressure ranged from 350 mm Hg to 200 mm Hg. The mean filling time ranged from 352 ms to 490 ms, for the diastolic pressure range of -60 mm Hg to 0 mm Hg. Esmolol produced a decrease in left ventricular pressure, required longer pump filling time, and reduced LVAD flow.     

Acute in vivo evaluation of an implantable continuous flow biventricular assist system

An implantable biventricular assist device offers a considerable opportunity to save the lives of patients with combined irreversible right and left ventricular failure. The purpose of this study was to evaluate the hemodynamic and physiologic performance of the combined implantation of the CorAide left ventricular assist device (LVAD) and the DexAide right ventricular assist device (RVAD). Acute hemodynamic responses were evaluated after simulating seven different physiological conditions in two calves. Evaluation was performed by fixing the speed of one individual pump and increasing the speed of the other. Under all conditions, increased LVAD or RVAD speed resulted in increased pump flow. The predominant pathophysiologic effect of independently varying DexAide and CorAide pump speeds was that the left atrial pressure was very sensitive to increasing RVAD speed above 2,400 rpm, whereas the right atrial pressure demonstrated much less sensitivity to increasing LVAD speed. An increase in aortic pressure and RVAD flow was observed while increasing LVAD speed, especially under low contractility, ventricular fibrillation, high pulmonary artery pressure, and low circulatory blood volume conditions. In conclusion, a proper RVAD-LVAD balance should be maintained by avoiding RVAD overdrive. Additional studies will further investigate the performance of these pumps in chronic animal models.     

Comparison of pulsatile with nonpulsatile mechanical support in a porcine model of profound cardiogenic shock

The aim of this study was to examine whether pulsatility by intraaortic balloon counterpulsation (IABP) is an important adjunct to the treatment of profound cardiogenic shock (CS) with a widely used, nonpulsatile centrifugal pump (CP). In each of 18 anesthetized, open chest pigs, the outflow cannula of the CP was inserted in the aortic arch through the right external carotid artery, and the inflow cannula of the CP was placed in the left atrium. A 40 cc IABP was subsequently placed in the descending aorta through the left external carotid artery. CS was induced by occlusion of coronary arteries and the infusion of propranolol and crystalloid fluid. Mean aortic pressure, pulse pressure, aortic end diastolic pressure, left ventricular end diastolic pressure, right atrial pressure, and heart rate were monitored. Cardiac output and left anterior descending artery flow were measured with a transit time ultrasound flowmeter. During profound CS, life sustaining hemodynamics were maintained only with the support of the assist devices. Hemodynamic support with the CP was associated with a nearly nonpulsatile flow and a pulse pressure of 7 +/- 4 mm Hg, which increased to 33 +/- 10 mm Hg (p = 0.000) after combining the CP with the IABP. Compared with the hemodynamic support offered by the CP alone, addition of the IABP increased mean aortic pressure from 40 +/- 15 to 50 +/- 16 mm Hg (p = 0.000), cardiac output from 810 +/- 194 to 1,200 +/- 234 ml/min (p = 0.003), and left anterior descending artery flow from 26 +/- 10 to 39 +/- 14 ml/min (p = 0.001). In profound CS, mechanical support provided by a continuous flow CP is enhanced by the added pulsatility of the IABP.     

Testing of a centrifugal blood pump with a high efficiency hybrid magnetic bearing

The purpose of this article is to present test results for a second generation, high efficiency, nonpulsatile centrifugal blood pump that is being developed for use as a left ventricular assist device (LVAD). The LVAD pump uses a hybrid passive-active magnetic bearing support system that exhibits extremely low power loss, low vibration, and high reliability under transient conditions and varying pump orientations. A unique feature of the second generation design configuration is the very simple and direct flow path for both main and washing blood flows. The pump was tested in both vertical and horizontal orientations using a standard flow loop to demonstrate the performance and durability of the second generation LVAD. Steady state and transient orientation pump operating characteristics including pressure, flow, speed, temperatures, vibration, and rotor orientation were measured. During the tests, pump performance was mapped at several operating conditions including points above and below the nominal design of 5 L/min at 100 mm Hg pressure rise. Flow rates from 2 to 7 L/min and pressure rises from 50 to 150 mm Hg were measured. Pump speeds were varied during these tests from 2,500 to 3,500 rpm. The nominal design flow of 5 L/min at 100 mm Hg pressure rise was successfully achieved at the design speed of 3,000 rpm. After LVAD performance testing, both 28 day continuous duty and 5 day transient orientation durability tests were completed without incident. A hydrodynamic backup bearing design feasibility study was also conducted. Results from this design study indicate that an integral hydrodynamic backup bearing may be readily incorporated into the second generation LVAD and other magnetically levitated pump rotors.     

Preload sensitivity of the Jarvik 2000 and HeartMate II left ventricular assist devices

The in vitro sensitivity of continuous flow pumps to preload and afterload pressure has been well characterized. We compared flow in the Jarvik 2000 and HeartMate II continuous flow left ventricular assist devices (LVADs) at different inflow and outflow pressures and different pump speeds. This allowed us to measure the impact of a changing inflow pressure on the pump flow rate at different speeds but against a constant afterload. The resulting preload sensitivity curves showed that, overall, both LVADs have a mean preload sensitivity of 0.07 L/min/mm Hg in the physiologic ranges of pressures and flows encountered during normal operation. The HeartMate II pump had an increased preload sensitivity (up to approximately 0.1 L/min/mm Hg) as the preload was increased. The preload sensitivity of the Jarvik 2000 LVAD was more variable, having several peaks and troughs as the preload was increased. In future LVADs, improved preload sensitivity may allow passive regulation of pump output, optimize ventricular unloading, and decrease the risk of ventricular suction by the pump.     

新一代左心室磁悬浮辅助泵血流动力学分析

目的降低左心室磁悬浮辅助泵的血栓形成概率和溶血风险,提升辅助泵供血效率。方法利用计算流体动力学方法,研究泵体出口直径、出口角度、出口与泵内壁面连接处圆角尺寸和转子与壳体间间隙对流场的影响,优化泵体内部结构,改善流体动力学性能。结果新一代左心室磁悬浮辅助泵与上一代辅助泵相比,泵内壁面最大壁面剪切应力(wall shear stress,WSS)降低约23. 6%,辅助泵内转子壁面最大WSS降低约47. 4%,WSS200 Pa区域面积降低约76. 2%,出口流量提升约14. 4%。结论新一代左心室磁悬浮辅助泵内部血流流迹趋于平缓,血流流体动力学性能有综合提升。研究结果为今后左心室磁悬浮辅助泵的优化设计及相关实验研究提供参考依据。     

Recovery directed left ventricular assist device: a new concept

To promote cardiac recovery, we developed a recovery directed left ventricular assist device (RDLVAD) that consists of a valved apical conduit, an afterload controlling chamber (ACC), and a pump. We evaluated its efficacy by comparison with an ordinary LVAD. In each of six pigs with ischemia-induced heart failure, flow and pressure measurements were made while maintaining the total blood flow and arterial pressure equal in the two groups. RDLVAD was able to direct all the blood ejected from the LV into the ACC (0-15 mm Hg) but not into the aorta (73 mm Hg). In the ordinary LVAD, however, some ejection occurred into the aorta despite vigorous suction of the LV. Thus, RDLVAD increased DPTI/SPTI 2.3 times (p < 0.005) and decreased left ventricular end-diastolic pressure by 40% and maximum dP/dt by 20% (p < 0.05). Even the apical valve, at approximately half the diameter of the aortic valve, was able to allow all the blood ejected from the LV to enter the ACC. In one control group pig that achieved almost no ejection into the aorta, left ventricular relaxation and dilatation was extremely limited. RDLVAD may promote cardiac recovery by ensuring less LV work, a greater blood supply/demand ratio in the coronary circulation, and full ventricular relaxation.     

Biventricular support with the Jarvik 2000 axial flow pump: a feasibility study

Patients with congestive heart failure who are supported with a left ventricular assist device (LVAD) may experience right ventricular dysfunction or failure that requires support with a right ventricular assist device (RVAD). To determine the feasibility of using a clinically available axial flow ventricular assist device as an RVAD, we implanted Jarvik 2000 pumps in the left ventricle and right atrium of two Corriente crossbred calves (approximately 100 kg each) by way of a left thoracotomy and then analyzed the hemodynamic effects in the mechanically fibrillated heart at various LVAD and RVAD speeds. Right atrial implantation of the device required no modification of either the device or the surgical technique used for left ventricular implantation. Satisfactory biventricular support was achieved during fibrillation as evidenced by an increase in mean aortic pressure from 34 mm Hg with the pumps off to 78 mm Hg with the pumps generating a flow rate of 4.8 L/min. These results indicate that the Jarvik 2000 pump, which can provide chronic circulatory support and can be powered by external batteries, is a feasible option for right ventricular support after LVAD implantation and is capable of completely supporting the circulation in patients with global heart failure.     

Computational Fluid Dynamics of Developing Avian Outflow Tract Heart Valves

Hemodynamic forces play an important role in sculpting the embryonic heart and its valves. Alteration of blood flow patterns through the hearts of embryonic animal models lead to malformations that resemble some clinical congenital heart defects, but the precise mechanisms are poorly understood. Quantitative understanding of the local fluid forces acting in the heart has been elusive because of the extremely small and rapidly changing anatomy. In this study, we combine multiple imaging modalities with computational simulation to rigorously quantify the hemodynamic environment within the developing outflow tract (OFT) and its eventual aortic and pulmonary valves. In vivo Doppler ultrasound generated velocity profiles were applied to Micro-Computed Tomography generated 3D OFT lumen geometries from Hamburger-Hamilton (HH) stage 16-30 chick embryos. Computational fluid dynamics simulation initial conditions were iterated until local flow profiles converged with in vivo Doppler flow measurements. Results suggested that flow in the early tubular OFT (HH16 and HH23) was best approximated by Poiseuille flow, while later embryonic OFT septation (HH27, HH30) was mimicked by plug flow conditions. Peak wall shear stress (WSS) values increased from 18.16 dynes/cm(2) at HH16 to 671.24?dynes/cm(2) at HH30. Spatiotemporally averaged WSS values also showed a monotonic increase from 3.03 dynes/cm(2) at HH16 to 136.50?dynes/cm(2) at HH30. Simulated velocity streamlines in the early heart suggest a lack of mixing, which differed from classical ink injections. Changes in local flow patterns preceded and correlated with key morphogenetic events such as OFT septation and valve formation. This novel method to quantify local dynamic hemodynamics parameters affords insight into sculpting role of blood flow in the embryonic heart and provides a quantitative baseline dataset for future research.     

Effect of left ventricular assist device outflow conduit anastomosis location on flow patterns in the native aorta

Computational fluid dynamics (CFD) models were developed to investigate the altered fluid dynamics of the native aorta in patients with a left ventricular assist device (LVAD). The objective of this study was to simulate the effect of LVAD aortic outflow conduit location on the 3-D flow in the native aorta over a range of boundary conditions. The fluid mechanics of three different surgical geometries [(P), proximal, (D), distal and (IP), in-plane] were studied and the implications for short- and long-term medical consequences explored by evaluating the flow fields, wall shear, and hemolysis. The greatest disruptions in the normal aortic flow pattern occurred with series flow conditions, when flow through the aortic valve was minimal. Under series conditions, circulation in the proximal aorta is retrograde, originating from the LVAD outflow conduit. The (P) geometry provided the most blood washout of the proximal aorta, with a larger region of slow-moving flow observed in the (D) and (IP) models. Wall shear stress was reduced for the (IP) geometry, which lacks the direct flow impingement present in the (P) and (D) models. Clinically, the (D) and (IP) geometries require less traumatic surgeries and probably are better tolerated by the patient. In this situation, the (IP) geometry suggests improvement in both increased flow to the proximal aorta and decreased shear stress compared with (D). However, the (D) and (IP) configurations are not recommended for patients with low or no flow from the heart because of the lack of blood washout near the aortic valve and therefore possible thrombus formation in that area.     

Effect of LVAD outflow conduit insertion angle on flow through the native aorta

BACKGROUND AND AIM: The goal of this study was to evaluate the effect of surgical anastomosis configuration of the aortic outflow conduit (AOC) from a continuous flow left ventricular assist device (LVAD) on the flow fields in the aorta using CFD simulations. The geometry of the surgical integration of the LVAD is an important factor in the flow pattern that develops both in series (aortic valve closed, all flow through LVAD) and in parallel (heart pumping in addition to LVAD). METHODS: CFD models of the AOC junctions simulate geometry as cylindrical tubes that intersect at angles ranging from 30 degrees to 90 degrees. Velocity fields are computed over a range of cardiac output for both series and parallel flow. RESULTS: Our results demonstrate that the flow patterns are significantly affected by the angle of insertion of the AOC into the native aorta, both during series and parallel flow conditions. Zones of flow recirculation and high shear stress on the aortic wall can be observed at the highest angle, gradually decreasing in size until disappearing at the lowest angle of 30 degrees. The highest velocity and shear stress values were associated with series flow. CONCLUSIONS: The results suggest that connecting the LVAD outflow conduit to the proximal aorta at a shallower angle produces fewer secondary flow patterns in the native cardiovascular system.     

Quantifying turbulent wall shear stress in a subject specific human aorta using large eddy simulation

In this study, large-eddy simulation (LES) is employed to calculate the disturbed flow field and the wall shear stress (WSS) in a subject specific human aorta. Velocity and geometry measurements using magnetic resonance imaging (MRI) are taken as input to the model to provide accurate boundary conditions and to assure the physiological relevance. In total, 50 consecutive cardiac cycles were simulated from which a phase average was computed to get a statistically reliable result. A decomposition similar to Reynolds decomposition is introduced, where the WSS signal is divided into a pulsating part (due to the mass flow rate) and a fluctuating part (originating from the disturbed flow). Oscillatory shear index (OSI) is plotted against time-averaged WSS in a novel way, and locations on the aortic wall where elevated values existed could easily be found. In general, high and oscillating WSS values were found in the vicinity of the branches in the aortic arch, while low and oscillating WSS were present in the inner curvature of the descending aorta. The decomposition of WSS into a pulsating and a fluctuating part increases the understanding of how WSS affects the aortic wall, which enables both qualitative and quantitative comparisons.     

The Flow Field along the Entire Length of Mouse Aorta and Primary Branches

There is a spatial disposition to atherosclerosis along the aorta corresponding to regions of flow disturbances. The objective of the present study is to investigate the detailed distribution of hemodynamic parameters (wall shear stress (WSS), spatial gradient of wall shear stress (WSSG), and oscillatory shear index (OSI)) in the entire length of C57BL/6 mouse aorta with all primary branches (from ascending aorta to common iliac bifurcation). The detailed geometrical parameters (e.g., diameter and length of the vessels) were obtained from casts of entire aorta and primary branches of mice. The flow velocity was measured at the inlet of ascending aorta using Doppler flowprobe in mice. The outlet pressure boundary condition was estimated based on scaling law. The continuity and Navier–Stokes equations were solved using three-dimensional finite element method (FEM). The model prediction was tested by comparing the computed flow rate with the flow rate measured just before the common iliac bifurcation, and good agreement was found. It was also found that complex flow patterns occur at bifurcations between main trunk and branches. The major branches of terminal aorta, with the highest proportion of atherosclerosis, have the lowest WSS, and the relatively atherosclerotic-prone aortic arch has much more complex WSS distribution and higher OSI value than other sites. The low WSS coincides with the high OSI, which approximately obeys a power law relationship. Furthermore, the scaling law between flow and diameter holds in the entire aorta and primary branches of mice under pulsatile blood flow conditions. This model will eventually serve to elucidate the causal relation between hemodynamic patterns and atherogenesis in KO mice.     

Outcomes of midterm circulatory support by left ventricular assist device implantation with descending aortic anastomosis

For some patients undergoing left ventricular assist device (LVAD) implantation, the perfusion tube is anastomosed to the descending aorta instead of the currently more prevalently used ascending aorta. Purpose of this study was to assess retrospectively the outcomes of LVAD patients with descending aortic anastomosis. Between March 2007 and March 2010, six patients underwent LVAD implantation with descending aortic anastomosis with Toyobo or Jarvik 2000 LVAD at our institute. Their average circulatory support time was 434 (range 82–751) days. Both types of LVAD afforded adequate circulatory support, and inotrope treatment and mechanical ventilation were discontinued relatively early. Echocardiograms of the three patients with Jarvik 2000 LVAD revealed antegrade flow in the ascending aorta during the intermittent low-speed period. Among them, one patient developed infarction in the right brain hemisphere because of thromboembolism, whereas another patient developed pneumonia in the left lung followed by a lethal systemic infection. One patient on Toyobo LVAD support reached heart transplantation without morbidity. Another patient implanted with Toyobo LVAD, whose left ventricular function was too poor to generate forward flow through aortic valve, developed thrombus in the ascending aorta. No embolic events were observed in the organs below the diaphragm. In conclusion, descending aortic anastomosis of the perfusion tube can be used for LVAD implantation for some patients, but considerable risks of morbidities, including thromboembolic events and/or infection, should be recognized.     

Effect of pump flow mode of novel left ventricular assist device upon end organ perfusion in dogs with doxorubicin induced heart failure

End organ effects of nonpulsatile (NP) and pulsatile (P) left ventricular assist device (LVAD) flow were compared in a canine model of doxorubicin-induced heart failure. After heart failure induction, a prototype bimodal LVAD was implanted. Hemodynamics, cardiac dimensions, and myocardial metabolism were monitored with the LVAD off (baseline) and on (in NP and P modes at 70% or 100% power). End organ perfusion was assessed by colored microsphere analysis. Seven dogs were used: two died before pump implantation and were excluded from analysis, and the remaining five survived to study termination. At 70% NP, ascending aortic flow and myocardial oxygen consumption (MVO2) decreased significantly. At 100% NP, LV dimensions decreased, aortic systolic, pulse, and LV pressures decreased but not significantly, and ascending aorta flow reversed. At 100% NP, coronary blood flow, MVO2, and LV free wall subepicardial and subendocardial blood flows decreased significantly. However, as NP support increased, the subepicardial/subendocardial blood flow ratio remained near baseline. At 100% NP, right ventricular perfusion decreased but not significantly, cerebral perfusion decreased significantly, and renal perfusion stayed constant. P mode results were similar, except that ascending aorta flow decreased significantly at 100% P instead of reversing as at 100% NP. These results suggest that end organ perfusion is not differentially affected by LVAD flow mode during chronic heart failure.